Upperton Pharma Solutions Recognised as One of The Sunday Times Best Places to Work 2026
We’re delighted to announce that Upperton has officially been accredited as one of The Sunday Times Best Places to Work 2026
Upperton Named Dual Winner at Medilink Midlands Awards, Underscoring Continued Growth and Commitment to Innovation
Upperton announces its recognition as winner of the Small Molecule Dosage Form category at the inaugural European CDMO Leadership Awards.
Risk Isn’t Inevitable: How the Right CDMO Partnership Protects Your Programme
What exactly is the difference between a CDMO, a CRO, and a CMO? Each plays a vital role in the life sciences ecosystem.
Liquid Injectables: Stability Issues and How to Avoid Them
What exactly is the difference between a CDMO, a CRO, and a CMO? Each plays a vital role in the life sciences ecosystem.
How are Parenteral Manufacturing Solutions Evolving to Meet the Demands for More Specialised and Sensitive Drug Formulations?
What exactly is the difference between a CDMO, a CRO, and a CMO? Each plays a vital role in the life sciences ecosystem.
Upperton Advances Sterile Manufacturing Facility with MHRA Submission
Upperton advances sterile manufacturing facility following MHRA submission.
How Upperton Has Evolved to Meet the Changing Needs of Biotechs
What exactly is the difference between a CDMO, a CRO, and a CMO? Each plays a vital role in the life sciences ecosystem.
What Biotech Startups Need to Know About Sterile Fill-Finish Services
What exactly is the difference between a CDMO, a CRO, and a CMO? Each plays a vital role in the life sciences ecosystem.
Low Bioburden Powders for Terminal Sterilisation: Raising the Standard in Modern Drug Development
The pressure of speed to clinic is continuing to increase. Biotechs are under more pressure, and therefore the CDMOs supporting them must evolve too
DDL 2025 – The Next Chapter in Inhalation
• The pressure of speed to clinic is continuing to increase. Biotechs are under more pressure, and therefore the CDMOs supporting them must evolve too